VNDA Vanda Pharmaceuticals PE ratio, current and historical analysis
The current PE ratio of VNDA can't be determined, as the TTM EPS of -$0.29 is negative. The last PE ratio of Vanda Pharmaceuticals, recorded in December 2023, was 105.5.
VNDA PE ratio history
The PE ratio of Vanda Pharmaceuticals has averaged 67.11 over the last ten years. Over the past ten years, VNDA's PE ratio was at its highest in the Jun 2018 quarter at 952.5, when the stock price was $19.05 and the EPS was $0.02. The lowest value was in the Mar 2020 quarter, when it reached 4.75 with a price of $10.36 and an EPS of $2.18.
Vanda Pharmaceuticals PE ratio by year
Maximum annual increase: 304.23% in 2020
Maximum annual decrease: -85.53% in 2019
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 105.5 | 57.04% |
| 2022 | 67.18 | 156.9% |
| 2021 | 26.15 | -14.43% |
| 2020 | 30.56 | 304.23% |
| 2019 | 7.56 | -85.53% |
| 2018 | 52.26 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | 24.69 | N/A |
VNDA average PE ratio chart
VNDA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 12.03 | $207.63B |
| MRK Merck & Co Inc | 20.85 | $252.61B |
| JNJ Johnson & Johnson | 25.79 | $374.39B |
| PFE Pfizer Inc | 33.07 | $142.41B |
| LLY ELI LILLY & Co | 80.72 | $711.91B |
| BMY Bristol Myers Squibb Co | N/A | $118.1B |
| VNDA Vanda Pharmaceuticals Inc | N/A | $288.04M |
Frequently asked questions
What is Vanda Pharmaceuticals's PE ratio?
The current price to earnings ratio of VNDA can't be calculated, as its EPS of -$0.29 is negative.
What is the 3-year average PE ratio for Vanda Pharmaceuticals (VNDA)?
The 3-year average PE ratio for VNDA stock is 47.71.
What is the 5-year average PE ratio for Vanda Pharmaceuticals (VNDA)?
The 5-year average PE ratio for VNDA stock is 35.02.
What is the highest PE ratio for VNDA?
The highest quarterly PE ratio in the last ten years has been 952.5 and it was in the Jun 2018 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.